[1]高 展),刘延方)#,王 冲),等.DNMT3A R882位点突变急性髓系白血病临床分析[J].郑州大学学报(医学版),2017,(03):300-303.[doi:10.13705/j.issn.1671-6825.2017.03.014]
 GAO Zhan),LIU Yanfang),WANG Chong),et al.Clinical characteristics of acute myeloid leukemia with DNMT3A R882 mutation[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(03):300-303.[doi:10.13705/j.issn.1671-6825.2017.03.014]
点击复制

DNMT3A R882位点突变急性髓系白血病临床分析()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年03期
页码:
300-303
栏目:
应用研究
出版日期:
2017-05-15

文章信息/Info

Title:
Clinical characteristics of acute myeloid leukemia with DNMT3A R882 mutation
作者:
高 展1)刘延方1)#王 冲1)周 阳1)朱颖超1)徐 衍1)董 丽1)侯 杰1)仝佳音1)刘若阳1)侯降雪1)李 涛2)张秋堂2)孙 慧1)孙 玲1)
1)郑州大学第一附属医院血液内科 郑州 450052 2)郑州大学第一附属医院血液病研究室 郑州 450052
Author(s):
GAO Zhan1)LIU Yanfang1)WANG Chong1)ZHOU Yang1)ZHU Yingchao1)XU Yan1)DONG Li1)HOU Jie1)TONG Jiayin1)LIU Ruoyang1)HOU Jiangxue1)
1)Department of Hematology, the First Affiliated Hospital, Zhengzhou University,Zhengzhou 450052 2)Institute of Hematology, the First Affiliated Hospital, Zhengzhou University,Zhengzhou 450052
关键词:
急性髓系白血病 DNMT3A R882位点突变 临床特征
Keywords:
acute myeloid leukemia DNMT3A R882 mutation clinical characteristics
分类号:
R733.71
DOI:
10.13705/j.issn.1671-6825.2017.03.014
摘要:
目的:分析DNMT3A R882位点突变急性髓系白血病(AML)患者的临床特征。方法:选取接受DNMT3A R882位点突变检测的168例初治AML患者,采用PCR联合基因测序法检测DNMT3A R882位点突变以及CEBPA、NPM1和FLT3-ITD突变,采用4色多参数流式细胞仪分析18种抗原在白血病细胞上的表达,K-M法绘制生存曲线用于预后分析。结果:共检出24例(14.29%)DNMT3A R882位点突变的AML患者。DNMT3A R882位点突变与未突变者比较,患者表现为高龄,发病时白细胞、血小板计数高,CD33和CD11b阳性率较高,CD34阳性率较低,易合并NPM1及FLT3-ITD基因突变; 第一疗程诱导化疗后完全缓解率与未突变组比较差异无统计学意义,但中位无事件生存时间缩短(62 d vs 277 d)。结论:DNMT3A R882位点突变的AML具有较显著的临床特征,预后差。
Abstract:
Aim: To explore the clinical characteristics of acute myeloid leukemia(AML)with DNMT3A R882 mutation.Methods: The clinical data of 168 AML patients undergoing detection of DNMT3A R882 loci mutation were collected retrospectively. Gene sequencing after PCR was used to detect the DNMT3A R882 loci mutation,as well as CEBPA, NPM1 and FLT3-ITD mutations. The expressions of 18 antigens on leukemic blasts were assessed by 4 color flow cytometry. The prognosis was analyzed using K-M curve.Results: DNMT3A R882 mutation was detected in 24 patients(14.29%). Compared with the patients without DNMT3A R882 mutation, the patients with DNMT3A R882 mutation tended to be more older, with higher white blood and platelet counts, with higher expressions of CD33 and CD11b and poorer expression of CD34, and more companied with NPM1 and FLT3-ITD mutations. The patients with DNMT3A R882 mutation had a shorter median event-free survival time than those without(62 d vs 277 d), but there was no significant difference in complete response rate after the first course of treatment.Conclusion: The AML patients with DNMT3A R882 mutation have obvious clinical features and a poor prognosis.

参考文献/References:

[1] 沈杨,陈赛娟.急性白血病基因突变与多步骤发病机制和临床相关性[J].中国科学:生命科学,2013,43(1):39
[2] 阴晓彤,饶钦辉,王玲,等.哺乳动物DNA甲基化修饰的动态调控机制[J].生命的化学,2014,34(5):604
[3] CHEN BF,CHAN WY.The de novo DNA methyltransferase DNMT3A in development and cancer[J].Epigenetics,2014,9(5):669
[4] ZARE-ABDOLLAHI D,SAFARI S,MOVAFAGH A,et al.A mutational and expressional analysis of DNMT3A in acute myeloid leukemia cytogenetic subgroups[J].Hematology,2015,20(7):397
[5] THOL F,DAMM F,LÜDEKING A,et al.Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia[J]. J Clin Oncol,2011,29(21): 2889
[6] RIBEIRO AF,PRATCORONA M,ROCKOVA V,et al.Mutant DNMT3A:a marker of poor prognosis in acute myeloid leukemia[J].Blood,2012,119(24):5824
[7] SHEN Y,ZHU YM,FAN X,et al.Gene mutation patterns and their prognostic impact in a cohort of 1,185 patients with acute myeloid leukemia[J].Blood,2011,118(20): 5593
[8] MARCUCCI G,METZELER KH,SCHWIND S,et al.Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia[J].J Clin Oncol,2012,30(7):742
[9] VARDIMAN JW,THIELE J,ARBER DA,et al.The 2008 revision of the World Health Organization(WHO)classification of myeloid neoplasms and acute leukemia: rationale and important changes[J].Blood,2009,114(5):937
[10]张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2008:106
[11]洪青晓,叶华丹,汤琳琳,等.急性髓系白血病相关基因的DNA甲基化[J].中国细胞生物学学报,2015,37(2):299
[12]IM AP,SEHGAL AR,CARROLL MP,et al.DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies associations with prognosis and potential treatment strategies[J].Leukemia,2014,28(9):1774
[13]CHEN MH,ATENAFU E,CRADDOCK KJ,et al.CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia[J].Leukemia Res,2013,37(2):122

相似文献/References:

[1]万鼎铭)△,边志磊),刘延方),等.急性髓系白血病患者骨髓WT1基因的表达与预后的关系[J].郑州大学学报(医学版),2014,(03):386.
 WAN Dingming),BIAN Zhilei),LIU Yanfang),et al.Prognostic value of WT1 expression in bone marrow for acute myeloid leukemia[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(03):386.
[2]刘延方,朱颖超,张秋堂,等.FLT3ITD突变急性髓系白血病的临床及免疫表型特征分析[J].郑州大学学报(医学版),2015,(03):441.

备注/Memo

备注/Memo:
#通信作者,男,1962年5月生,博士,教授,主任医师,研究方向:血液病的基础与临床,E-mail:liuyf371@163.com
更新日期/Last Update: 2017-05-20